# A Phase 1 Study of Tegoprazan on Healthy Male Volunteers

> **NCT03530228** · PHASE1 · UNKNOWN · sponsor: **HK inno.N Corporation** · enrollment: 44 (estimated)

## Conditions studied

- Pharmacodynamics
- Pharmacokinetics
- Healthy Male Volunteers

## Interventions

- **DRUG:** Tegoprazan (C1)
- **DRUG:** Tegoprazan (C1)
- **DRUG:** Treatment C: Tegoprazan (C1)
- **DRUG:** Tegoprazan (C2)
- **DRUG:** Tegoprazan (C2)
- **DRUG:** Esomeprazole (C2)
- **DRUG:** Tegoprazan (C3)

## Key facts

- **NCT ID:** NCT03530228
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2018-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03530228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03530228, "A Phase 1 Study of Tegoprazan on Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03530228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*